THE WORLD HEALTH ORGANISATION, or WHO, has issued global guidelines on the usage of GLP-1 medicines, also known as “skinny jabs,” in order to treat obesity. The announcement of the guidelines aims “to address the growing global health challenge of obesity, which affects more than 1 billion people,” according to the international organisation. “Skinny jabs,” which include appetite suppressants…